Resources

Type of publications
Regions
Diseases

5192 results found

2024 ∙ Nakabembe, E. Cooper, J. Amaral, K. Tusubira, V. Hsia, Y. Abu-Raya, B. Sekikubo, M. Nakimuli, A. Sadarangani, M. Le Doare, K.

The safety and immunogenicity of vaccines administered to pregnant women living with HIV: a systematic review and meta-analysis

  • Pregnant women
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2024 ∙ Han, Y. Wang, X. Li, X. Zhong, Z.

The willingness of healthcare workers to be vaccinated against monkeypox and their knowledge about monkeypox: A systematic review and meta-analysis

  • Healthcare workers
  • Mpox
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Zarkesh, M. Sanoie, M. Heydarzadeh, S. Abooshahab, R. Daneshafrooz, A. Hosseinpanah, F. Hedayati, M.

Thyroid Function in the Time of COVID-19: A Systematic Review of Disease Progression and Vaccination Effect

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ De Weerdt, L. Herzog, S. A. Van Damme, P. Maertens, K.

Timing of pertussis vaccination during pregnancy: Evidence and implementation - A systematic review

  • Pregnant women
  • Pertussis
  • Administration
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Solomon-Rakiep, T. Olivier, J. Amponsah-Dacosta, E.

Towards contextualized complex systems approaches to scaling-up hepatitis B birth-dose vaccination in the African region: a qualitative systematic review

  • Africa
  • Pregnant women
  • Parents/caregivers
  • Healthcare workers
  • Children
  • Hepatitis B
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Thompson, K. M. Kalkowska, D. A. Kidd, S. E. Burns, C. C. Badizadegan, K.

Trade-offs of different poliovirus vaccine options for outbreak response in the United States and other countries that only use inactivated poliovirus vaccine (IPV) in routine immunization

  • All age groups
  • Poliomyelitis
  • Modeling
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Veroniki, A. A. Thirugnanasampanthar, S. S. Konstantinidis, M. Dourka, J. Ghassemi, M. Neupane, D. Khan, P. Nincic, V. Corry, M. Robson, R. Parker, A. Soobiah, C. Sinilaite, A. Doyon-Plourde, P. Gil, A. Siu, W. Moqueet, N. Stevens, A. English, K. Florez, I. D. Yepes-Nunez, J. J. Hutton, B. Muller, M. Moja, L. Straus, S. Tricco, A. C.

Trivalent and quadrivalent seasonal influenza vaccine in adults aged 60 and older: a systematic review and network meta-analysis

  • Adults
  • Older adults
  • Influenza
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
High
2024 ∙ Nwachukwu, G. Rihan, A. Nwachukwu, E. Uduma, N. Elliott, K. S. Tiruneh, Y. M.

Understanding COVID-19 Vaccine Hesitancy in the United States: A Systematic Review

  • Americas
  • United States of America
  • All age groups
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Essa-Hadad, J. Gorelik, Y. Vervoort, J. Jansen, D. Edelstein, M.

Understanding the health system barriers and enablers to childhood MMR and HPV vaccination among disadvantaged, minority or underserved populations in middle- and high-income countries: a systematic review

  • All age groups
  • Healthcare workers
  • Parents/caregivers
  • Measles
  • Mumps
  • Rubella
  • Human papillomavirus (HPV)
  • Acceptance
  • Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Petras, M. Janovska, D. Lomozova, D. Franklova, M. Dlouhy, P. Rosina, J. Lesna, I. K.

Understanding the time-driven shifts of vaccine effectiveness against any and severe COVID-19 before and after the surge of Omicron variants within 2.5 years of vaccination: A meta-regression

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...